Els Van Peer1, Frank Jacobs2, Jan Snoeys2, Jos Van Houdt2, Ils Pijpers2, Christophe Casteleyn1, Chris Van Ginneken1, Steven Van Cruchten3. 1. Laboratory of Applied Veterinary Morphology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium. 2. Janssen R&D, Beerse, Belgium. 3. Laboratory of Applied Veterinary Morphology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium. steven.vancruchten@uantwerpen.be.
Abstract
PURPOSE: In view of pediatric drug development, juvenile animal studies are gaining importance. However, data on drug metabolizing capacities of juvenile animals are scarce, especially in non-rodent species. Therefore, we aimed to characterize the in vitro biotransformation of four human CYP450 substrates and one UGT substrate in the livers of developing Göttingen minipigs. METHODS: Liver microsomes from late fetal, Day 1, Day 3, Day 7, Day 28, and adult male and female Göttingen minipigs were incubated with a cocktail of CYP450 substrates, including phenacetin, tolbutamide, dextromethorphan, and midazolam. The latter are probe substrates for human CYP1A2, CYP2C9, CYP2D6, and CYP3A4, respectively. In addition, the UGT multienzyme substrate (from the UGT-GloTM assay), which is glucuronidated by several human UGT1A and UGT2B enzymes, was also incubated with the porcine liver microsomes. RESULTS: For all tested substrates, drug metabolism significantly rose postnatally. At one month of age, 60.5 and 75.4% of adult activities were observed for acetaminophen and dextrorphan formations, respectively, while 35.4 and 43.2% of adult activities were present for 4-OH-tolbutamide and 1'-OH-midazolam formations. Biotransformation of phenacetin was significantly higher in 28-day-old and adult females compared with males. CONCLUSIONS: Maturation of metabolizing capacities occurred postnatally, as described in man.
PURPOSE: In view of pediatric drug development, juvenile animal studies are gaining importance. However, data on drug metabolizing capacities of juvenile animals are scarce, especially in non-rodent species. Therefore, we aimed to characterize the in vitro biotransformation of four human CYP450 substrates and one UGT substrate in the livers of developing Göttingen minipigs. METHODS: Liver microsomes from late fetal, Day 1, Day 3, Day 7, Day 28, and adult male and female Göttingen minipigs were incubated with a cocktail of CYP450 substrates, including phenacetin, tolbutamide, dextromethorphan, and midazolam. The latter are probe substrates for humanCYP1A2, CYP2C9, CYP2D6, and CYP3A4, respectively. In addition, the UGT multienzyme substrate (from the UGT-GloTM assay), which is glucuronidated by several humanUGT1A and UGT2B enzymes, was also incubated with the porcine liver microsomes. RESULTS: For all tested substrates, drug metabolism significantly rose postnatally. At one month of age, 60.5 and 75.4% of adult activities were observed for acetaminophen and dextrorphan formations, respectively, while 35.4 and 43.2% of adult activities were present for 4-OH-tolbutamide and 1'-OH-midazolam formations. Biotransformation of phenacetin was significantly higher in 28-day-old and adult females compared with males. CONCLUSIONS: Maturation of metabolizing capacities occurred postnatally, as described in man.
Authors: Els Van Peer; Lies De Bock; Koen Boussery; Jan Van Bocxlaer; Christophe Casteleyn; Chris Van Ginneken; Steven Van Cruchten Journal: Basic Clin Pharmacol Toxicol Date: 2015-05-18 Impact factor: 4.080
Authors: C Cazeneuve; G Pons; E Rey; J M Treluyer; T Cresteil; G Thiroux; P D'Athis; G Olive Journal: Br J Clin Pharmacol Date: 1994-05 Impact factor: 4.335
Authors: Miriam Ayuso; Laura Buyssens; Marina Stroe; Allan Valenzuela; Karel Allegaert; Anne Smits; Pieter Annaert; Antonius Mulder; Sebastien Carpentier; Chris Van Ginneken; Steven Van Cruchten Journal: Pharmaceutics Date: 2020-12-30 Impact factor: 6.321
Authors: Laura Buyssens; Laura De Clerck; Wim Schelstraete; Maarten Dhaenens; Dieter Deforce; Miriam Ayuso; Chris Van Ginneken; Steven Van Cruchten Journal: Front Pharmacol Date: 2021-04-15 Impact factor: 5.810
Authors: Joske Millecam; Laura De Clerck; Elisabeth Govaert; Mathias Devreese; Elke Gasthuys; Wim Schelstraete; Dieter Deforce; Lies De Bock; Jan Van Bocxlaer; Stanislas Sys; Siska Croubels Journal: Front Pharmacol Date: 2018-05-14 Impact factor: 5.810